[Subacute cutaneous lupus observed during treatment with thiazide diuretics].
D000368:Aged; D001581:Benzothiadiazines / Q000008:administration & dosage; D004232:Diuretics; D004338:Drug Combinations / Q000008:administration & dosage / Q000009:adverse effects; D005260:Female; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000139:chemically induced* / Q000276:immunology / Q000473:pathology; D012867:Skin / Q000473:pathology; D049993:Sodium Chloride Symporter Inhibitors / Q000009:adverse effects*; D013148:Spironolactone / Q000009:adverse effects; D013449:Sulfonamides / Q000009:adverse effects; D014223:Triamterene / Q000008:administration & dosage
D001581:Benzothiadiazines; D004232:Diuretics; D004338:Drug Combinations; D049993:Sodium Chloride Symporter Inhibitors; D013449:Sulfonamides; C035057:cyclothiazide, triamterene drug combination; D013148:Spironolactone; C026063:spironolactone, althiazide drug combination; D014223:Triamterene
Lupus cutané subaigu observé au cours d'un traitement par diurétiques thiazidiques.